The following individual and combined search terms were used: GLP-1, Semaglutide and Liraglutide, molecular mechanism, lipid metabolism, insulin metabolism, glucose homeostasis, energy expenditure obesity treatment, type 2 diabetes mellitus, side effects, clinical trials, treatment option, fatty liver disease, hypertension, neurodegenerative diseases, cardiovascular diseases, therapeutic options. Only articles published in the last 10 years are included, although older pivotal studies were added
Instances of delayed gastric emptying can occur even after patients have been taking GLP-1 RAs for more than three years
What to expect during a protocol Mild soreness at the injection site is the most common experience, typically resolving within minutes to hours
Theres no research yet on how effective it is to take doses less frequently
The approved label is broad, an add-on to diet and exercise for adults with high cholesterol including the inherited kind, and it does not require you to fail anything first
